Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Morfini

Showing results (81-90 of 151) with videos related to

Pageof 16
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 1999
Knowledge of HIV/AIDS and emotional adjustment in a cohort of men with haemophilia and HIV infection: final reportE Pasqual Marsettin, N Ciavarella, C Lobaccaro, et al.
Journal of Clinical and Hospital Pharmacy|June 1, 1984
Individualization of Factor VIII dosageA Messori, G Longo, M Morfini, et al.
British Journal of Haematology|September 1, 1993
Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patientsG Longo, C Natoli, D Rafanelli, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
European study on orthopaedic status of haemophilia patients with inhibitorsM Morfini, S Haya, G Tagariello, et al.
Thrombosis Research|August 1, 1993
Pharmacokinetics, thrombogenicity and safety of a double-treated prothrombin complex concentrateM Morfini, G Longo, E Berntorp, et al.
Annals of Internal Medicine|August 1, 1985
No hepatitis after treatment with a modified factor IX concentrate in previously untreated hemophiliacsP M Mannucci, M Morfini, L Gatti, et al.
Clinical Cardiology|October 1, 1986
Platelet function and coagulation studies in patients with mitral valve prolapseA Zuppiroli, F Cecchi, M Ciaccheri, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 30, 2011
Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®)--an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia AU Martinowitz, J Bjerre, B Brand, et al.
Computer Programs in Biomedicine|January 1, 1985
A calculator program for clinical application of the Bayesian method of predicting plasma drug levelsS Ruffo, A Messori, T H Grasela, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 23, 2011
When should prophylaxis therapy in inhibitor patients be considered?G Young, G Auerswald, V Jimenez-Yuste, et al.
Pageof 16

Showing results (81-90 of 151) with videos related to

Sort By:
Pageof 16
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 1999
Knowledge of HIV/AIDS and emotional adjustment in a cohort of men with haemophilia and HIV infection: final reportE Pasqual Marsettin, N Ciavarella, C Lobaccaro, et al.
Journal of Clinical and Hospital Pharmacy|June 1, 1984
Individualization of Factor VIII dosageA Messori, G Longo, M Morfini, et al.
British Journal of Haematology|September 1, 1993
Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patientsG Longo, C Natoli, D Rafanelli, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
European study on orthopaedic status of haemophilia patients with inhibitorsM Morfini, S Haya, G Tagariello, et al.
Thrombosis Research|August 1, 1993
Pharmacokinetics, thrombogenicity and safety of a double-treated prothrombin complex concentrateM Morfini, G Longo, E Berntorp, et al.
Annals of Internal Medicine|August 1, 1985
No hepatitis after treatment with a modified factor IX concentrate in previously untreated hemophiliacsP M Mannucci, M Morfini, L Gatti, et al.
Clinical Cardiology|October 1, 1986
Platelet function and coagulation studies in patients with mitral valve prolapseA Zuppiroli, F Cecchi, M Ciaccheri, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 30, 2011
Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®)--an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia AU Martinowitz, J Bjerre, B Brand, et al.
Computer Programs in Biomedicine|January 1, 1985
A calculator program for clinical application of the Bayesian method of predicting plasma drug levelsS Ruffo, A Messori, T H Grasela, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 23, 2011
When should prophylaxis therapy in inhibitor patients be considered?G Young, G Auerswald, V Jimenez-Yuste, et al.
Pageof 16